Pharmacotherapeutic potential of astaxanthin: Human and animal targeting roles – A review
Publicado en línea: 19 jul 2022
Páginas: 829 - 838
Recibido: 18 nov 2021
Aceptado: 31 ene 2022
DOI: https://doi.org/10.2478/aoas-2022-0017
Palabras clave
© 2022 Mohammed F. El Basuini et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
The recent pandemic stress and the impacts of climatic changes on humans’ and animals’ health status and well-being resulted in severe drawbacks. Initially, stress-induced oxidation resulting from the generation of free radicals led to the impairment of cellular function and a high possibility of attack with infection. Astaxanthin is a bioactive material derived from fish, crustaceans, and algae with high antioxidative potential. Astaxanthin is a lipid-soluble carotenoid that can easily cross through the cellular membrane layers to catch the reactive oxygen metabolites. Astaxanthin also has pigmentation properties making it suitable for pharmaceutical, cosmetic, nutraceutical, agriculture, and aquaculture sectors. Recently, astaxanthin is suggested as a natural scavenger for free radicals induced by COVID-19. Besides, using astaxanthin as antioxidative and immunostimulant agents is well-reported in several clinical studies. The output of these investigations should be simplified and presented to the scientific community to utilize the available information and fill the gap of knowledge. Also, it is necessary to update the researchers with the recent recommendations of applying astaxanthin